Phreesia, Inc.

For the period ended Apr 30, 2026. Filed May 28, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Apr 30, 2026 · Filed May 28, 2026

PHR$12.90+2.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 1. Financial Statements:

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

Consolidated Balance Sheets

	April 30, 2026	January 31, 2026
(Unaudited)
Assets
Current:
Cash, cash equivalents and restricted cash (including restricted cash of $— and $1,691 as of April 30, 2026 and January 31, 2026, respectively)	$74,706	$73,830
Settlement assets	32,720	32,999
Accounts receivable, net of allowance for doubtful accounts of $1,467 and $1,523 as of April 30, 2026 and January 31, 2026, respectively	89,607	97,453
Cardholder receivables	29,740	38,330
Deferred purchase price receivables	23,247	18,003
Accrued interest and fees receivables	711	840
Deferred contract acquisition costs	401	410
Prepaid expenses and other current assets	16,129	17,978
Total current assets	267,261	279,843
Property and equipment, net of accumulated depreciation and amortization of $90,385 and $94,193 as of April 30, 2026 and January 31, 2026, respectively	20,568	20,332
Capitalized internal-use software, net of accumulated amortization of $73,362 and $69,390 as of April 30, 2026 and January 31, 2026, respectively	54,624	54,270
Operating lease right-of-use assets	1,769	2,002
Deferred contract acquisition costs	231	338
Intangible assets, net of accumulated amortization of $16,099 and $13,489 as of April 30, 2026 and January 31, 2026, respectively	77,151	79,761
Goodwill	169,513	170,064
Deferred tax assets	1,593	1,593
Other assets (includes $1,691 and $— of long-term restricted cash as of April 30, 2026 and January 31, 2026, respectively)	7,283	2,442
Long-term cardholder receivables	59,494	47,723
Long-term deferred purchase price receivables	6,654	5,422
Total Assets	$666,141	$663,790
Liabilities and Stockholders’ Equity
Current:
Settlement obligations	$32,720	$32,999
Current portion of debt and finance lease liabilities	5,301	7,971
Current portion of operating lease liabilities	1,062	1,254
Accounts payable	11,891	11,477
Accrued expenses	30,521	41,257
Due to healthcare providers	30,331	38,056
Deferred revenue	39,561	49,522
Other current liabilities	722	705
Total current liabilities	152,109	183,241
Long-term debt and finance lease liabilities	85,303	92,117
Operating lease liabilities, non-current	891	1,107
Long-term due to healthcare providers	60,826	45,329
Long-term deferred revenue	3,223	244
Long-term deferred tax liabilities	4,624	4,498
Other long-term liabilities	75	47
Total Liabilities	307,051	326,583
Commitments and contingencies (Note 11)
Stockholders’ Equity:
Preferred stock, undesignated, $0.01 par value—20,000,000 shares authorized as of both April 30, 2026 and January 31, 2026; no shares issued or outstanding as of both April 30, 2026 and January 31, 2026	—	—
Common stock, $0.01 par value—500,000,000 shares authorized as of both April 30, 2026 and January 31, 2026; 63,249,229 and 62,020,186 shares issued as of April 30, 2026 and January 31, 2026, respectively	632	620
Additional paid-in capital	1,201,871	1,181,679
Accumulated deficit	(796,227)	(799,190)
Accumulated other comprehensive loss	(571)	(382)
Treasury stock, at cost, 1,474,884 and 1,355,169 shares as of April 30, 2026 and January 31, 2026, respectively	(46,615)	(45,520)
Total Stockholders’ Equity	359,090	337,207
Total Liabilities and Stockholders’ Equity	$666,141	$663,790

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.